BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dou H, Song A, Jia S, Zhang L. Heparinoids Danaparoid and Sulodexide as clinically used drugs. Progress in Molecular Biology and Translational Science 2019. [DOI: 10.1016/bs.pmbts.2019.02.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Kasdekar N, Walke G, Deshpande K, Hotha S. Glycosyl Vinylogous Carbonates as Glycosyl Donors by Metal-Free Activation. J Org Chem 2022. [PMID: 35414184 DOI: 10.1021/acs.joc.1c02427] [Reference Citation Analysis]
2 Zhang Y, Ma X, Zhang L. Glycosaminoglycan Quality Control by Monosaccharide Analysis. Methods Mol Biol 2022;2303:297-306. [PMID: 34626388 DOI: 10.1007/978-1-0716-1398-6_24] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Duan Z, Yao J, Duan N, Wang M, Wang S. Sulodexide Prevents Peritoneal Fibrosis by Downregulating the Expression of TGF-β1 and Its Signaling Pathway Molecules. Evid Based Complement Alternat Med 2021;2021:2052787. [PMID: 34497655 DOI: 10.1155/2021/2052787] [Reference Citation Analysis]
4 Pérez-Campos Mayoral L, Hernández-Huerta MT, Papy-García D, Barritault D, Zenteno E, Sánchez Navarro LM, Pérez-Campos Mayoral E, Matias Cervantes CA, Martínez Cruz M, Mayoral Andrade G, López Cervantes M, Vázquez Martínez G, López Sánchez C, Pina Canseco S, Martínez Cruz R, Pérez-Campos E. Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation. Mol Cell Biochem 2021;476:3815-25. [PMID: 34110554 DOI: 10.1007/s11010-021-04204-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Özbalci D. COVID-19’DA ANTİKOAGÜLAN TEDAVİ. SDÜ Tıp Fakültesi Dergisi 2021. [DOI: 10.17343/sdutfd.899521] [Reference Citation Analysis]
6 Colarossi G, Maffulli N, Trivellas A, Schnöring H, Hatam N, Tingart M, Migliorini F. Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis. Int J Clin Pharm 2021;43:825-38. [PMID: 33774764 DOI: 10.1007/s11096-021-01260-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
7 Walke G, Kasdekar N, Sutar Y, Hotha S. Silver-assisted gold-catalyzed formal synthesis of the anticoagulant Fondaparinux pentasaccharide. Commun Chem 2021;4:15. [PMID: 36697540 DOI: 10.1038/s42004-021-00452-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Magnani HN. Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection. Clin Appl Thromb Hemost 2021;27:1076029620977702. [PMID: 33539214 DOI: 10.1177/1076029620977702] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
9 Meng H, Jin W, Yu L, Xu S, Wan H, He Y. Protective effects of polysaccharides on cerebral ischemia: A mini-review of the mechanisms. Int J Biol Macromol 2021;169:463-72. [PMID: 33347928 DOI: 10.1016/j.ijbiomac.2020.12.124] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
10 Song CH, Shin DS, Jang JW, Kim TL, Kim YG, Kim JS, Seo HM. A Case of Livedoid Vasculopathy Successfully Treated with Sulodexide. Ann Dermatol 2020;32:508-11. [PMID: 33911794 DOI: 10.5021/ad.2020.32.6.508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Gonzalez Ochoa AJ, Carrillo J, Manríquez D, Manrique F, Vazquez AN. Reducing hyperpigmentation after sclerotherapy: A randomized clinical trial. J Vasc Surg Venous Lymphat Disord 2021;9:154-62. [PMID: 32739509 DOI: 10.1016/j.jvsv.2020.06.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost 2020;120:1004-24. [PMID: 32473596 DOI: 10.1055/s-0040-1713152] [Cited by in Crossref: 150] [Cited by in F6Publishing: 179] [Article Influence: 50.0] [Reference Citation Analysis]
13 Ziganshina MM, Yarotskaya EL, Bovin NV, Pavlovich SV, Sukhikh GT. Can Endothelial Glycocalyx Be a Major Morphological Substrate in Pre-Eclampsia? Int J Mol Sci 2020;21:E3048. [PMID: 32357469 DOI: 10.3390/ijms21093048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
14 Gao Y, Zhang L, Jiao W. Marine glycan-derived therapeutics in China. Progress in Molecular Biology and Translational Science 2019. [DOI: 10.1016/bs.pmbts.2019.02.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]